SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-22-059813
Filing Date
2022-05-13
Accepted
2022-05-13 06:50:42
Documents
55
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q lptx-20220331x10q.htm   iXBRL 10-Q 1024098
2 EXHIBIT 31.1 lptx-20220331xex31d1.htm EX-31.1 13963
3 EXHIBIT 32.1 lptx-20220331xex32d1.htm EX-32.1 9000
  Complete submission text file 0001104659-22-059813.txt   4839333

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lptx-20220331.xsd EX-101.SCH 35468
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lptx-20220331_cal.xml EX-101.CAL 36779
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lptx-20220331_def.xml EX-101.DEF 127349
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20220331_lab.xml EX-101.LAB 355284
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20220331_pre.xml EX-101.PRE 246339
49 EXTRACTED XBRL INSTANCE DOCUMENT lptx-20220331x10q_htm.xml XML 809263
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 22920189
SIC: 2834 Pharmaceutical Preparations